Stay updated with breaking news from Partial Response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FOSTER CITY, Calif., Oct. 26, 2023 -- Apollomics Inc. , today announced a report by the Veneto Institute of Oncology on the efficacy response of a patient treated with vebreltinib for GBM with...
– Meaningful antitumor activity observed in recurrent/metastatic HRAS mutant HNSCC, including CR –
Jayme Heim, MSN, FNP-BC; and Lauren Miller, MPAS, PA-C, share thoughts on the use of oral systemic and biologic treatments in plaque psoriasis, commenting on the need for personalized care for patients.
/PRNewswire/ -- Medivir AB (Nasdaq:MVIR) (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high...
GVHD experts outline the treatment options for patients with steroid-refractory chronic GVHD.